Research Analysts Set Expectations for CAPR FY2026 Earnings
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Capricor Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company will post earnings per share of ($1.12) for […]
Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Capricor Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska anticipates that the biotechnology company will post earnings per share of ($1.12) for […]
